US$ 28.73
retatrutide 2.5 mg The Retatrutide Dosage Chart
Description
Cotadutide, a glucagon-like protein-1 receptor (GLP-1R) and glucagon receptor (GCGR) agonist, was shown to reduce blood glycaemia, body weight and hepatic steatosis in people with type 2 diabetes mellitus

That exceeds the results from every other weight loss medication tested in clinical settings, including Tirzepatide at 20.9% and Semaglutide at 14.9%

(In the past, Siegel received research funds from Vivus, which makes Qsymia, a weight-loss medication that is not a GLP-1 agonist.) GLP-1 agonist medications cause the pancreas to release insulin, which helps control blood sugar, and they slow your gastrointestinal tract down, making you feel full longer and reducing hunger, he explains

Protein requirements during aggressive weight loss exceed those for weight maintenance

H., Ergenc, M

Quick Answer: Success on GLP-1 medications requires a protein-first, fiber-rich eating strategy with 80-120g protein daily (20-35g per meal), 25-38g fiber, moderate healthy fats, and smaller, more frequent meals to manage side effects
